<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">


Press Releases

Our latest announcements

Biodesix to Present at Leerink Partners 5th Annual Global Healthcare Conference

Biodesix CEO David Brunel will present a corporate overview on Deep Phenotyping, Machine Learning to Precision Medicine at the Leerink Partners Conference

Biodesix’ GeneStrat Blood-Based Mutation Test Now Includes EML4-ALK Fusions

GeneStrat blood-based mutation testing for advanced lung cancer offers significant advantages for patients and their treating physicians over standard tissue testing, which can delay treatment.

Biodesix to Present Data on Blood Based Diagnostic Tests for Patients with Non-Small Cell Lung Cancer (NSCLC)

Biodesix data on proteomic and genomic blood-based assays presented at EORTC

Investigational Blood Test Identifies Patients with Melanoma Who Are More Likely to Have Improved Survival on Nivolumab Therapy; Biodesix’ blood test is independent of PD-L1 expression

Investigational blood test identifies patients with melanoma who are more likely to have improved survival on Nivolumab therapy.

VeriStrat and Epidermal Growth Factor Receptor Mutation Status Study Results Presented at 16th World Conference On Lung Cancer

VeriStrat and Epidermal Growth Factor Receptor Mutation Status Study results presented at 16th World Conference on Lung Cancer

Biodesix Named To Inc. 500|5000 Fastest-Growing Private Companies List

Biodesix named to Inc. 500|5000 Fastest-Growing Private Companies list

Biodesix Adds Biognosys’ Proteomics Technology To Its Diagnostic Development Capabilities; Collaboration Enables Protein Identification Within Proteomic Signatures

Biodesix recently added Biognosys' Proteomics to their capabiltites.

Health Net, Inc. Provides Coverage for Biodesix’ VeriStrat Test 

HealthNet now covers Biodesix' VeriStrat test

Biodesix Raises Follow-On Series E Financing

Biodesix raises follow-on series E financing

Aetna Provides Coverage for Biodesix’ VeriStrat Test

Biodesix announced that the VeriStrat® test is now considered a medically necessary benefit by Aetna Corporation.